Drugs / Influsplit SSW®/Fluarix™
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00731393 Comparator | Oct 2003 → Aug 2004 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influsplit SSW/Fluarix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00731393 ↗ |
| Modality | Vaccine | “Influsplit SSW®/Fluarix™ 2003/2004” NCT00731393 ↗ |
| Route | Intramuscular | “intramuscular injection” NCT00731393 ↗ |